FLT1 and astrocytoma (excluding glioblastoma): Moreover, it has been recently described a heterogeneous expression pattern of VEGF as well as VEGFR1 and 2 among astrocytomas of different grades and that beneficial response to Bevacizumab treatment is independent of the expression of VEGF and its co-receptors [38].